Filter
890
Filtered Results: 890
Text search:
Zhang,
J.
Featured
Recommendations
83
New Publications
100
Language
Document type
No document type
286
Studies & Reports
264
Guidelines
234
Manuals
44
Fact sheets
30
Strategic & Response Plan
17
Training Material
8
Brochures
3
Situation Updates
2
Infographics
2
Countries / Regions
Global
57
Russia
44
Brazil
25
Germany
21
Latin America and the Carribbean
19
Middle East and North Africa
16
Africa
15
India
15
Western and Central Europe
13
Syria
12
Yemen
12
South Africa
10
Ukraine
9
Eastern Europe and Central Asia
9
Spain
9
Eastern Europe
9
China
8
Peru
8
Kenya
7
Asia
7
Ecuador
7
Philippines
6
Mozambique
6
Uganda
6
South Sudan
6
Indonesia
6
Chile
5
South–East Asia Region
5
Argentina
5
Vietnam
5
Sudan
5
Ethiopia
5
Angola
5
Myanmar / Burma
5
Colombia
4
Ghana
4
Sierra Leone
4
Nigeria
4
Cambodia
4
Tanzania
4
Congo, Democratic Republic of
4
West and Central Africa
4
Paraguay
4
France
4
Bangladesh
4
Nepal
3
Mexico
3
Benin
3
Senegal
3
Malawi
3
Italy
3
Guinea-Bissau
3
North America
3
Bolivia
3
Sri Lanka
3
Mali
3
Tajikistan
2
Canada
2
Congo-Brazzaville
2
Niger
2
Burkina Faso
2
Haiti
2
Venezuela
2
Saudi Arabia
2
Western Pacific Region
2
Portugal
2
East and Southern Africa
2
Lebanon
2
Egypt
2
Botswana
2
North Korea
1
Switzerland
1
Timor Leste/ East Timor
1
Thailand
1
El Salvador
1
Lesotho
1
Turkey
1
Rwanda
1
Kazakhstan
1
Cameroon
1
Iran
1
Albania
1
Laos
1
Kyrgyzstan
1
Zimbabwe
1
Austria
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Armenia
1
Dominican Republic
1
Jordan
1
Tunisia
1
United Kingdom
1
Belarus
1
Israel
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Nicaragua
1
Honduras
1
Chad
1
Libya
1
Bhutan
1
Zambia
1
Iraq
1
Somalia
1
Liberia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
264
Clinical Guidelines
82
Public Health
69
Women & Child Health
39
Key Resources
15
Pharmacy & Technologies
7
Capacity Building
1
Toolboxes
COVID-19
274
Mental Health
77
Planetary Health
62
HIV
61
NCDs
58
NTDs
39
TB
33
Disability
23
AMR
18
Caregiver
15
Health Financing Toolbox
15
Pharmacy
13
Rapid Response
11
Global Health Education
11
Refugee
10
Ebola & Marburg
9
Natural Hazards
7
Conflict
3
Zika
2
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Цель данного доклада – стать ресурсом, позволяющим руководителям и другим заинтересованным сторонам рассматри-вать предупреждение самоубийств как императив. То...
Infection preventions
Hygiene
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
BackgroundClimate change is one of the great challenges of our time. The consequences of climate change on exposed biological subjects, as well as on vulnerable societies, are a concern for the entire scientific community. Rising temperatures, heat waves, floods, tornadoes, hurricanes, droughts, fir...
H2 TIC disorders
recommended
Practical considerations
It provides more detailed and practical guidance for continuing services for each life stage across the life-course continuum. As such, both documents should be read and used together. The countries in South-East Asia and the Pacific regions would like to adapt the guidance...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Global AIDS Update 2018
Closing Gaps
Breaking Barriers
Righting injustices
Directions in Development
Human Development
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
Consensual Recommendation for treatment of COVID-19 in older adults
Air pollution is a major environmental risk factor and contributor to chronic, noncommunicable diseases (NCDs). However, most public health approaches to NCD prevention focus on behavioural and biomedical risk factors, rather than environmental risk factors such as air pollution. This article discus...
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping laboratory services producing comparable and reliable ...
